多发性骨髓瘤骨病临床诊疗专家共识（2021）

2022-01-15 中国临床肿瘤学会临床肿瘤学杂志

多发性骨髓瘤骨病(MBD)是多发性骨髓瘤(MM)患者的常见并发症,严重影响其生活质量和生存期,因此强调规范化的诊断和治疗。

中文标题：

发布机构：

中国临床肿瘤学会

发布日期：

2022-01-15

简要介绍：

多发性骨髓瘤骨病(MBD)是多发性骨髓瘤(MM)患者的常见并发症,严重影响其生活质量和生存期,因此强调规范化的诊断和治疗。此次中国临床肿瘤学会(CSCO)指南工作委员会组织专家组,在2014版MBD专家共识的基础上进行了更新补充,推荐对于初治的MM患者,无论是否存在骨病的影像学证据,均应使用双膦酸盐和/或地舒单抗积极预防MBD及骨相关事件。在双膦酸盐使用期间,应该密切监测肾功能及颌骨改变,对于肾功能不全的患者需要减量甚至禁用,同时这类患者宜优先选用地舒单抗。希望本共识作为学术性指导意见,能够提供恰当的临床诊疗参考,以便使患者获得最佳的治疗,具体实施时应该根据患者的个体情况而定。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=d25001c002351375, title=多发性骨髓瘤骨病临床诊疗专家共识（2021）, enTitle=, guiderFrom=临床肿瘤学杂志, authorId=0, author=, summary=多发性骨髓瘤骨病(MBD)是多发性骨髓瘤(MM)患者的常见并发症,严重影响其生活质量和生存期,因此强调规范化的诊断和治疗。, cover=https://img.medsci.cn/2022211/1644591017549_5579292.jpg, journalId=0, articlesId=null, associationId=2393, associationName=中国临床肿瘤学会, associationIntro=中国临床肿瘤学会(CSCO)指南工作委员会, copyright=0, guiderPublishedTime=Sat Jan 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">多发性骨髓瘤骨病(MBD)是多发性骨髓瘤(MM)患者的常见并发症,严重影响其生活质量和生存期,因此强调规范化的诊断和治疗。此次中国临床肿瘤学会(CSCO)指南工作委员会组织专家组,在2014版MBD专家共识的基础上进行了更新补充,推荐对于初治的MM患者,无论是否存在骨病的影像学证据,均应使用双膦酸盐和/或地舒单抗积极预防MBD及骨相关事件。在双膦酸盐使用期间,应该密切监测肾功能及颌骨改变,对于肾功能不全的患者需要减量甚至禁用,同时这类患者宜优先选用地舒单抗。希望本共识作为学术性指导意见,能够提供恰当的临床诊疗参考,以便使患者获得最佳的治疗,具体实施时应该根据患者的个体情况而定。 </span></p>, tagList=[TagDto(tagId=321, tagName=多发性骨髓瘤), TagDto(tagId=37825, tagName=多发性骨髓瘤骨病), TagDto(tagId=40191, tagName=血液系统恶性肿瘤), TagDto(tagId=117037, tagName=髓系疾病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6829, appHits=579, showAppHits=0, pcHits=1596, showPcHits=6249, likes=3, shares=85, comments=6, approvalStatus=1, publishedTime=Sat Feb 12 15:46:00 CST 2022, publishedTimeString=2022-01-15, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Feb 11 22:50:01 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 15:43:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=多发性骨髓瘤骨病临床诊疗专家共识（2021）.pdf)])

多发性骨髓瘤骨病临床诊疗专家共识（2021）.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2099534, encodeId=2ec92099534e1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Thu Nov 10 07:02:22 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221065, encodeId=8301122106573, content=学习了，有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=905a6504814, createdName=ms9000000871618265, createdTime=Thu May 19 22:51:28 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211017, encodeId=535f121101eaf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ee2199321, createdName=120ae86am56(暂无昵称), createdTime=Thu Apr 14 00:03:07 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207385, encodeId=fcb6120e3856f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:07:14 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205168, encodeId=3b361205168aa, content=<a href='/topic/show?id=53631019937c' target=_blank style='color:#2F92EE;'>#骨髓瘤骨病#</a>学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101993, encryptionId=53631019937c, topicName=骨髓瘤骨病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx98uribY0qWPsbFp1V2GFiaGl8MB6wnRviaico1FzULI2CicdAL60UW1Fgas2z8br6WLCltjIrEiaic89A/132, createdBy=8ebd5235386, createdName=椒芽, createdTime=Wed Mar 23 10:30:31 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
2022-11-10 ms6000000074653151

学习了

53 0
[GetPortalCommentsPageByObjectIdResponse(id=2099534, encodeId=2ec92099534e1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Thu Nov 10 07:02:22 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221065, encodeId=8301122106573, content=学习了，有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=905a6504814, createdName=ms9000000871618265, createdTime=Thu May 19 22:51:28 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211017, encodeId=535f121101eaf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ee2199321, createdName=120ae86am56(暂无昵称), createdTime=Thu Apr 14 00:03:07 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207385, encodeId=fcb6120e3856f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:07:14 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205168, encodeId=3b361205168aa, content=<a href='/topic/show?id=53631019937c' target=_blank style='color:#2F92EE;'>#骨髓瘤骨病#</a>学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101993, encryptionId=53631019937c, topicName=骨髓瘤骨病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx98uribY0qWPsbFp1V2GFiaGl8MB6wnRviaico1FzULI2CicdAL60UW1Fgas2z8br6WLCltjIrEiaic89A/132, createdBy=8ebd5235386, createdName=椒芽, createdTime=Wed Mar 23 10:30:31 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
2022-05-19 ms9000000871618265

学习了，有指导意义

0 0
[GetPortalCommentsPageByObjectIdResponse(id=2099534, encodeId=2ec92099534e1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Thu Nov 10 07:02:22 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221065, encodeId=8301122106573, content=学习了，有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=905a6504814, createdName=ms9000000871618265, createdTime=Thu May 19 22:51:28 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211017, encodeId=535f121101eaf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ee2199321, createdName=120ae86am56(暂无昵称), createdTime=Thu Apr 14 00:03:07 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207385, encodeId=fcb6120e3856f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:07:14 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205168, encodeId=3b361205168aa, content=<a href='/topic/show?id=53631019937c' target=_blank style='color:#2F92EE;'>#骨髓瘤骨病#</a>学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101993, encryptionId=53631019937c, topicName=骨髓瘤骨病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx98uribY0qWPsbFp1V2GFiaGl8MB6wnRviaico1FzULI2CicdAL60UW1Fgas2z8br6WLCltjIrEiaic89A/132, createdBy=8ebd5235386, createdName=椒芽, createdTime=Wed Mar 23 10:30:31 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
2022-04-14 120ae86am56(暂无昵称)

好

45 0
[GetPortalCommentsPageByObjectIdResponse(id=2099534, encodeId=2ec92099534e1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Thu Nov 10 07:02:22 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221065, encodeId=8301122106573, content=学习了，有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=905a6504814, createdName=ms9000000871618265, createdTime=Thu May 19 22:51:28 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211017, encodeId=535f121101eaf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ee2199321, createdName=120ae86am56(暂无昵称), createdTime=Thu Apr 14 00:03:07 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207385, encodeId=fcb6120e3856f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:07:14 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205168, encodeId=3b361205168aa, content=<a href='/topic/show?id=53631019937c' target=_blank style='color:#2F92EE;'>#骨髓瘤骨病#</a>学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101993, encryptionId=53631019937c, topicName=骨髓瘤骨病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx98uribY0qWPsbFp1V2GFiaGl8MB6wnRviaico1FzULI2CicdAL60UW1Fgas2z8br6WLCltjIrEiaic89A/132, createdBy=8ebd5235386, createdName=椒芽, createdTime=Wed Mar 23 10:30:31 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
2022-03-30 283488816

学习了

63 0
[GetPortalCommentsPageByObjectIdResponse(id=2099534, encodeId=2ec92099534e1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Thu Nov 10 07:02:22 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221065, encodeId=8301122106573, content=学习了，有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=905a6504814, createdName=ms9000000871618265, createdTime=Thu May 19 22:51:28 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211017, encodeId=535f121101eaf, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ee2199321, createdName=120ae86am56(暂无昵称), createdTime=Thu Apr 14 00:03:07 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207385, encodeId=fcb6120e3856f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:07:14 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205168, encodeId=3b361205168aa, content=<a href='/topic/show?id=53631019937c' target=_blank style='color:#2F92EE;'>#骨髓瘤骨病#</a>学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101993, encryptionId=53631019937c, topicName=骨髓瘤骨病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epx98uribY0qWPsbFp1V2GFiaGl8MB6wnRviaico1FzULI2CicdAL60UW1Fgas2z8br6WLCltjIrEiaic89A/132, createdBy=8ebd5235386, createdName=椒芽, createdTime=Wed Mar 23 10:30:31 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
2022-03-23 椒芽

#骨髓瘤骨病#学习了

65 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤指南

多发性骨髓瘤骨病临床诊疗专家共识（2021）

相关指南

科室

工具

服务